drugset / Trial / NCT00578097
Efficacy and Safety Study of Botulinum Toxin Type-A (Dysport®) in Continent Female Subjects Suffering From Idiopathic Overactive Bladder
RandomizedParallel-groupDouble-blindTreatment
Summary
The purpose of this study is to determine the optimal dose of botulinum toxin type A injected in the detrusor muscle to improve urinary symptoms, urodynamic parameters and quality of life of continent women suffering from idiopathic overactive bladder.
Timeline
- Start
- 2008-02
- Primary completion
- 2009-06
- Completion
- 2009-12
Outcome
Outcome not reported
Stopped (Enrollment): “The study was terminated early due to poor recruitment.”
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Botulinum toxin type A | Protein / enzyme biologic | 125 iu | Other |
| Subject | Botulinum toxin type A | Protein / enzyme biologic | 250 iu | Other |
| Subject | Botulinum toxin type A | Protein / enzyme biologic | 500 iu | Other |